About Pinteon Therapeutics
Pinteon Therapeutics is a private company based in Newton Centre, Massachusetts. It has reported $39,192,030 raised in two offerings on Form D since July 2014.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 7, 2022 | Jan 11, 2022amended Nov 12, 2025 | $29,185,713of $32.0M target | 2 | $14.5M | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Jul 8, 2014 | Jul 22, 2014amended Aug 22, 2017 | $10,006,317of $17.5M target | 1 | $10.0M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, two offerings | $39,192,030 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pinteon Therapeutics's Form D filed Nov 12, 2025.
WN
Westley Nolin
Director
JD
Jason Dinges
President and director
Earlier filings also listed Jeffrey Ives (director, last listed Aug 2017).
Sources
- SECPinteon Therapeutics, Inc. Form D/A, filed Nov 12, 2024
- SECPinteon Therapeutics, Inc. Form D/A, filed Nov 15, 2023
- SECPinteon Therapeutics, Inc. Form D, filed Jan 11, 2022
- SECPinteon Therapeutics, Inc. Form D/A, filed Aug 26, 2016
- SECPinteon Therapeutics, Inc. Form D, filed Jul 22, 2014
- SECPinteon Therapeutics, Inc. filing history